In the future, it would be interesting to examine the levels of CCR7 in the actual tumor cells of breast cancer patients in the absence of infiltrating immune cells to better confirm that ET-1 combined with CCR7 promotes migration of tumor cells to the lymph nodes. Here, CCR7 is linked to breast cancer.